YU16902A - Farmaceutski rastvori levosimendana - Google Patents

Farmaceutski rastvori levosimendana

Info

Publication number
YU16902A
YU16902A YU16902A YUP16902A YU16902A YU 16902 A YU16902 A YU 16902A YU 16902 A YU16902 A YU 16902A YU P16902 A YUP16902 A YU P16902A YU 16902 A YU16902 A YU 16902A
Authority
YU
Yugoslavia
Prior art keywords
levosimendan
solutions
pharmaceutical solutions
infusion
useful
Prior art date
Application number
YU16902A
Other languages
English (en)
Inventor
Reijo Backstrom
Paivi Granvik
Ritva Haikala
Sirpa Pelttari
Eva Saukko
Reija Yrjola
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8555263&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU16902(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of YU16902A publication Critical patent/YU16902A/sh
Publication of RS50445B publication Critical patent/RS50445B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Ovaj pronalazak se odnosi na rastvore levosimendana za farmaceutsku upotrebu, a naročito za intravenoznu primenu. Rastvori prema pronalasku imaju povećanu stabilnost i oni su naročito korisni kao infuzioni ili injekcioni rastvori ili infuzioni koncentrati. Levosimendan je koristan u tretiranju kongestivnog srčanog udara.
YUP-169/02A 1999-09-10 2000-09-08 Farmaceutski rastvori levosimendana RS50445B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI991925A FI109659B (fi) 1999-09-10 1999-09-10 Levosimendaanin farmaseuttisia liuoksia

Publications (2)

Publication Number Publication Date
YU16902A true YU16902A (sh) 2004-09-03
RS50445B RS50445B (sr) 2010-03-02

Family

ID=8555263

Country Status (39)

Country Link
US (2) US6730673B1 (sh)
EP (1) EP1210085B1 (sh)
JP (1) JP4708648B2 (sh)
KR (1) KR100869752B1 (sh)
CN (1) CN1203855C (sh)
AR (1) AR025449A1 (sh)
AT (1) ATE315937T1 (sh)
AU (1) AU771027B2 (sh)
BG (1) BG65827B1 (sh)
BR (1) BRPI0013924B8 (sh)
CA (1) CA2382013C (sh)
CO (1) CO5180582A1 (sh)
CZ (1) CZ303095B6 (sh)
DE (1) DE60025627T2 (sh)
DK (1) DK1210085T3 (sh)
EA (1) EA005067B1 (sh)
EE (1) EE05375B1 (sh)
ES (1) ES2256034T3 (sh)
FI (1) FI109659B (sh)
HK (1) HK1049282B (sh)
HR (1) HRP20020298B1 (sh)
HU (1) HU228340B1 (sh)
IL (2) IL148379A0 (sh)
IS (1) IS2244B (sh)
ME (1) ME00523B (sh)
MX (1) MXPA02002423A (sh)
MY (1) MY125984A (sh)
NO (1) NO331989B1 (sh)
NZ (1) NZ517605A (sh)
PL (1) PL202356B1 (sh)
PT (1) PT1210085E (sh)
RS (1) RS50445B (sh)
SI (1) SI1210085T1 (sh)
SK (1) SK287154B6 (sh)
TR (1) TR200200620T2 (sh)
TW (1) TWI242434B (sh)
UA (1) UA73954C2 (sh)
WO (1) WO2001019334A2 (sh)
ZA (1) ZA200201828B (sh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
CN100367964C (zh) * 2004-04-29 2008-02-13 王思清 左西孟旦-β环糊精包含物制剂
JP2008530186A (ja) * 2005-02-18 2008-08-07 オリオン コーポレーション 心不全治療法
JP2010514778A (ja) * 2006-12-28 2010-05-06 オリオン コーポレーション 非経口投与のためのレボシメンダン製剤
US10046081B2 (en) 2008-04-11 2018-08-14 The Henry M Jackson Foundation For The Advancement Of Military Medicine, Inc. Electrospun dextran fibers and devices formed therefrom
WO2012093404A2 (en) * 2011-01-03 2012-07-12 Gufic Biosciences Limited Parenteral formulations of levosimendan
US8697118B2 (en) * 2011-10-18 2014-04-15 St. Teresa Medical, Inc. Stabilizers for hemostatic products
US9808529B2 (en) * 2012-05-18 2017-11-07 Luoda Pharma Pty Ltd Liquid formulation
CN105106113B (zh) * 2015-09-30 2019-07-26 济南康和医药科技有限公司 一种左西孟旦注射液及其制备方法
SI3370693T1 (sl) * 2015-11-06 2020-07-31 Carinopharm Gmbh Izboljšane formulacije levosimendana za intravensko dajanje kot infuzija ali injekcija in infuzijski koncentrat
US10828387B2 (en) 2015-11-12 2020-11-10 St. Teresa Medical, Inc. Method of sealing a durotomy
CN108261398A (zh) * 2016-12-30 2018-07-10 齐鲁制药有限公司 一种含有左西孟旦的供注射用药物制剂及其制备方法
US10953128B2 (en) 2017-11-02 2021-03-23 St. Teresa Medical, Inc. Fibrin sealant products
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)
CN111514147B (zh) * 2020-05-12 2021-09-17 成都欣捷高新技术开发股份有限公司 用于急性失代偿心力衰竭症状的左西孟旦钠药用组合物及制备方法
US11760730B2 (en) 2021-01-11 2023-09-19 Navinta, Llc Process for the preparation of high purity Levosimendan
TR2021013305A2 (tr) * 2021-08-23 2023-03-21 Tuem Ekip Ilac Anonim Sirketi Li̇yofi̇li̇ze levosi̇mendan formülasyonlari
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英（江苏）药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法
CN116473930B (zh) * 2023-05-17 2023-12-15 山东泰合医药科技有限公司 一种注射用左西孟旦及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI980902A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia

Also Published As

Publication number Publication date
UA73954C2 (uk) 2005-10-17
SK287154B6 (sk) 2010-01-07
PL354028A1 (pl) 2003-12-15
FI19991925L (fi) 2001-03-10
SK3272002A3 (en) 2002-12-03
BR0013924B1 (pt) 2013-09-24
HRP20020298B1 (hr) 2007-02-28
NZ517605A (en) 2003-08-29
MXPA02002423A (es) 2002-08-12
KR20020048400A (ko) 2002-06-22
AU7004400A (en) 2001-04-17
PT1210085E (pt) 2006-05-31
EA005067B1 (ru) 2004-10-28
HUP0202749A2 (hu) 2003-02-28
PL202356B1 (pl) 2009-06-30
TWI242434B (en) 2005-11-01
HK1049282A1 (en) 2003-05-09
WO2001019334A3 (en) 2001-11-15
JP2003509351A (ja) 2003-03-11
CA2382013A1 (en) 2001-03-22
HK1049282B (zh) 2005-12-30
DE60025627D1 (de) 2006-04-06
CA2382013C (en) 2009-08-11
NO20021090L (no) 2002-03-05
BR0013924A (pt) 2002-05-21
KR100869752B1 (ko) 2008-11-21
HUP0202749A3 (en) 2003-03-28
ATE315937T1 (de) 2006-02-15
CZ303095B6 (cs) 2012-03-28
MY125984A (en) 2006-09-29
AU771027B2 (en) 2004-03-11
NO20021090D0 (no) 2002-03-05
FI109659B (fi) 2002-09-30
HRP20020298A2 (en) 2003-06-30
CN1373665A (zh) 2002-10-09
IL148379A (en) 2006-12-10
ZA200201828B (en) 2003-08-27
US6730673B1 (en) 2004-05-04
HU228340B1 (en) 2013-03-28
DE60025627T2 (de) 2006-11-16
BG106589A (bg) 2002-11-29
IS2244B (is) 2007-05-15
JP4708648B2 (ja) 2011-06-22
ME00523B (me) 2011-10-10
US6943164B2 (en) 2005-09-13
CN1203855C (zh) 2005-06-01
IL148379A0 (en) 2002-09-12
CO5180582A1 (es) 2002-07-30
AR025449A1 (es) 2002-11-27
BG65827B1 (bg) 2010-02-26
BRPI0013924B8 (pt) 2021-05-25
EA200200348A1 (ru) 2002-08-29
DK1210085T3 (da) 2006-05-08
IS6296A (is) 2002-03-06
EE05375B1 (et) 2011-02-15
CZ2002788A3 (cs) 2002-11-13
WO2001019334A2 (en) 2001-03-22
RS50445B (sr) 2010-03-02
EP1210085A2 (en) 2002-06-05
SI1210085T1 (sl) 2006-04-30
US20040106617A1 (en) 2004-06-03
TR200200620T2 (tr) 2002-09-23
EP1210085B1 (en) 2006-01-18
NO331989B1 (no) 2012-05-21
ES2256034T3 (es) 2006-07-16
EE200200129A (et) 2003-04-15

Similar Documents

Publication Publication Date Title
MY125984A (en) Pharmaceutical solutions of levosimendan.
SE0001899D0 (sv) New compounds
GEP20063799B (en) Tropane derivatives useful in therapy
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
TNSN06036A1 (en) Pyridyl derivatives and their use as therapeutic agents
GEP20053673B (en) Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
TNSN06033A1 (en) Piperazine derivatives and their use as therapeutic agents
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
MA28012A1 (fr) Derives de pyridyle et utilisation de ceux-ci en tant qu'agents therapeutiques
MEP36608A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
ES2177483T1 (es) Lucha contra la infeccion en sistemas de distribucion.
AU3850600A (en) Dalda analogs and their use
MXPA03011480A (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
SE9802206D0 (sv) Novel compounds
DE60025698D1 (de) Neue dialysemethode
EA200400548A1 (ru) Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
SE9802208D0 (sv) Novel compounds
ATE290396T1 (de) Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament
PL334437A1 (en) Pharmaceutical compositions for use in haemodialysis and pertitoneal dialysis as well as method of performing the both dialysis type using such compositions